Does epclusa cause fatigue or headaches?

Does Epclusa cause fatigue or headaches?

Epclusa is a combination antiviral medication used to treat chronic hepatitis C. It contains sofosbuvir and velpatasvir. Studies show that fatigue and headaches are among the most commonly reported side effects.

How common are fatigue and headaches with Epclusa?

In clinical trials, fatigue occurred in 22% of patients taking Epclusa, while headaches were reported by 21% of patients. These rates waren't significantly higher than those observed in placebo groups, so many experts consider them mild and consistent with the disease itself.

What happens if someone gets fatigue or headaches on Epclusa?

Most patients find these symptoms mild and go away after the 12-week treatment ends. If symptoms persist or grow stärker, patients should speak to their doctor. Some may need to adjust their treatment or find ways to manage the symptoms.

Can other medications or conditions cause these symptoms instead?

Yes. Fatigue and headaches can overlap with hepatitis C infection itself or with any ribavirin combination therapy that Epclusa may be paired with. Patients taking Epclusa alone or with ribavirin must track their symptoms and report any new or unusual ones to their doctor.

Are there alternatives if Epclusa produces strong fatigue or headaches?

Yes. Doctors may switch to other direct-acting antivirals such as Harvoni, Mavyret, or Vosevi if side effects become bothersome. Patients can also manage mild symptoms with rest, hydration, and proper diet.

When does patent expire for Epclusa?

Epclusa patent expires in 2032. The manufacturer, Gilead Sciences, has already filed several extensions and extension requests. Companies are challenging this patent through litigation.